• Users Online: 50
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2021  |  Volume : 9  |  Issue : 3  |  Page : 86-89

The nexus between mucormycosis and COVID-19: A review


1 Department of Oral & Maxillofacial Surgery, Vyas Dental College and Hospital, Jodhpur, Rajasthan, India
2 Department of Oral Medicine Diagnosis and Radiology, Vyas Dental College and Hospital, Jodhpur, Rajasthan, India

Correspondence Address:
Dr. Sugandha Arya
Department of Oral Medicine Diagnosis and Radiology, Vyas Dental College and Hospital, Jodhpur, Rajasthan.
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/INJO.INJO_22_21

Rights and Permissions

Mucormycosis is a disease of the diseased. Infection arises through inhalation of spores, contamination of the traumatized tissue, ingestion, and direct inoculation. High incidence of mucormycosis is seen in uncontrolled diabetic or immuno-compromised patients. Recently, its appearance has been linked with the COVID-19-affected individuals who are being treated by excess steroids or on other immunosuppressants and those with history of systemic disease. Therefore, for successful management, excessive steroids and immunosuppressive drugs should be avoided in mild cases of COVID-19.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed371    
    Printed20    
    Emailed0    
    PDF Downloaded41    
    Comments [Add]    

Recommend this journal